Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | ALPG | P10696 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16383050 | 0.85 | ALOX15 (0.57) | ALOX15CYP2C9CYP2C19KMT2AMEN1 | |
| SCHEMBL3898377 | 0.82 | ALOX15 (0.74) | ALOX15KMT2AMEN1ALPLALPI | |
| SCHEMBL244446 | 0.81 | ALOX15 (0.52) | ALOX15CYP2C9CYP2C19KMT2AMEN1 | |
| SCHEMBL11031303 | 0.80 | KMT2A (0.57) | KMT2AMEN1GAAALDH1A1RAB9A | |
| SCHEMBL6136246 | 0.80 | WDR5 (0.53) | GAAALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL4939704 | 0.80 | ALOX15 (0.47) | ALOX15CYP2C9CYP2C19KMT2AMEN1 | |
| SCHEMBL11285014 | 0.80 | ALOX15 (0.55) | ALOX15CYP2C9CYP2C19KMT2AMEN1 | |
| SCHEMBL9303147 | 0.80 | ALOX15 (0.50) | ALOX15CYP2C9CYP2C19KMT2AMEN1 | |
| SCHEMBL16601102 | 0.78 | ALOX15 (0.49) | ALOX15CYP2C9CYP2C19KMT2AMEN1 | |
| SCHEMBL15396047 | 0.78 | ALOX15 (0.68) | ALOX15KMT2AMEN1ALPLALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2545583-B1 | METHODS AND COMPOSITIONS FOR DOPING SILICON SUBSTRATES WITH MOLECULAR MONOLAYERS | VERSUM MAT US LLC (US) | 2020-05-13 | — | — | EP | claimed |
| US-20150011755-A1 | AMINE SALTS OF PROSTAGLANDIN ANALOGS | DR. REDDYS LABORATORIES LIMITED (IN) | 2015-01-08 | — | — | US | claimed |
| EP-2812314-A1 | AMINE SALTS OF PROSTAGLANDIN ANALOGS | Dr. Reddy's Laboratories Ltd. (IN) | 2014-12-17 | — | — | EP | claimed |
| US-8906774-B2 | Methods and compositions for doping silicon substrates with molecular monolayers | DYNALOY, LLC (US) | 2014-12-09 | — | — | US | claimed |
| WO-2013118058-A1 | AMINE SALTS OF PROSTAGLANDIN ANALOGS | DR.REDDYS LABORATORIES LIMITED (IN) | 2013-08-15 | — | — | WO | claimed |
| EP-2545583-A1 | METHODS AND COMPOSITIONS FOR DOPING SILICON SUBSTRATES WITH MOLECULAR MONOLAYERS | Dynaloy, LLC (US) | 2013-01-16 | — | — | EP | claimed |
| EP-2545583-B1 | METHODS AND COMPOSITIONS FOR DOPING SILICON SUBSTRATES WITH MOLECULAR MONOLAYERS | VERSUM MAT US LLC (US) | 2020-05-13 | — | — | EP | disclosed |
| US-10103401-B2 | Polymer electrolyte composition and polymer electrolyte membrane, polymer electrolyte membrane with catalyst layer, membrane electrode assembly, and polymer electrolyte fuel cell each using the same | TORAY INDUSTRIES, INC. (JP) | 2018-10-16 | — | — | US | disclosed |
| EP-3131145-B1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTROLYTE ASSEMBLY, AND SOLID POLYMER FUEL CELL USING SAME | TORAY INDUSTRIES (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-20170125832-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, POLYMER ELECTROLYTE MEMBRANE WITH CATALYST LAYER, MEMBRANE ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL EACH USING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3131145-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTROLYTE ASSEMBLY, AND SOLID POLYMER FUEL CELL USING SAME | Toray Industries, Inc. (JP) | 2017-02-15 | — | — | EP | disclosed |
| EP-2669280-B1 | BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES | ONO PHARMACEUTICAL CO (JP) | 2016-04-27 | — | — | EP | disclosed |
| US-9150537-B2 | Bicyclic compound and use thereof for medical purposes | ONO PHARMACEUTICAL CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-4116988-A | 16-Phenoxy prostaglandin E1 analogs | THE UPJOHN COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4116989-A | 16-Phenoxy prostaglandin F1α analogs | THE UPJOHN COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4087616-A | 16-Phenoxy prostaglandin A2 analogs | THE UPJOHN COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4087604-A | Substituted ω-pentanorprostaglandins | PFIZER INC. (US) | 1978-05-02 | — | — | US | disclosed |
| US-4065472-A | TISSUE SPECIFICITY | PFIZER INC. (US) | 1977-12-27 | — | — | US | disclosed |
| US-4024179-A | Substituted ω-pentanorprostaglandins | PFIZER INC. (US) | 1977-05-17 | — | — | US | disclosed |
| US-3931279-A | 5-Oxa prostaglandin F2.sub.α analogs | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011755-A1 | AMINE SALTS OF PROSTAGLANDIN ANALOGS | PTGIS, PTGER1, PTGER2 | ALOX15 81/4885CYP2C9 772/4885CYP2C19 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.